The Voice of Patients in Rare Disease Treatments: What's Considered in NICE Decisions?
Patient organizations play a crucial role in health technology assessments (HTAs), particularly for ultra-rare diseases. But how much do their inputs really matter? A recent study dug into 15 NICE appraisals from January 2022 to August 2024. They found that patients mainly talked about the disease i